Roxee Medication Guide

Gabapentin

Medication reference facts with explicit FDA-approval, off-label, source-limited, and safety context. Roxee does not sell, prescribe, or dispense medications.

Both Reference partial Not FDA-approved for animals Multiple FDA labelers Official label facts Owner quick guide first

Start Symptom Intake Talk to a Vet / Find a Vet Near You

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Some reference facts for this medication are still being verified.

Not FDA-approved as an animal drug. No FDA-approved animal-drug application is linked for this record. It may represent extra-label, human-drug, bulk-compounding, export-only, or otherwise unapproved animal-use source data; use only under veterinarian direction. Do not start, stop, or change treatment without your veterinarian.

Data freshness

Reference facts

Reference refreshed

Aug 6, 2026, 7:47 p.m.

Roxee has a partial reference profile for this medication. Some primary facts still need verification.

FDA applications

FDA application data refreshed

Aug 6, 2026, 7:47 p.m.

Sponsor, product, and application records imported from Animal Drugs @ FDA.

Safety reports

Safety data refreshed

Aug 6, 2026, 7:49 p.m.

openFDA reaction terms and case summaries are supporting evidence, not proof of causality.

Source timing details

Reference facts: Source Roxee | Refreshed Aug 6, 2026, 7:47 PM UTC
The reference fact projection used for browse cards and quick facts.
Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Aug 6, 2026, 7:47 PM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
openFDA reaction terms: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
openFDA case summaries: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC

Illustration placeholder

Gabapentin

Drug type: Generic ingredient • Branded profile • Not FDA-approved for animals

Both 86% reference complete

Species: Both

Approval status: Not FDA-approved as an animal drug. No FDA-approved animal-drug application is linked for this record. It may represent extra-label, human-drug, bulk-compounding, export-only, or otherwise unapproved animal-use source data; use only under veterinarian direction.

Medication Snapshot

Merged from the current Roxee medication system with field-level provenance, freshness, and completeness tracking.

Gabapentin

Used for neuropathic pain and as an adjunct for seizure control; also used for situational anxiety/sedation in some cases. Species commonly shown: Both.

Generic name

Gabapentin

Brand names

GABAPENTIN, SolutitionKits

Manufacturer

Multiple FDA labelers

Species

Both

Completeness

86%

Validation

Incomplete

Brand names

GABAPENTIN SolutitionKits

Indications / Uses

Used for neuropathic pain and as an adjunct for seizure control; also used for situational anxiety/sedation in some cases.

Administration / How To Give

Oral

Storage

Store at room temperature.

Warnings / Contraindications

Use caution with kidney disease; dose adjustments may be needed.

Use caution with kidney disease; dose adjustments may be needed.

Side Effects

Sedation, ataxia, mild GI upset.

FAQ

Both

Store at room temperature.

Related Medications

Related Conditions

Pain (acute, chronic)

Source Transparency

Verified source: https://www.roxee.ai/meds/
Verified source: https://animaldrugsatfda.fda.gov
Verified source: https://animaldrugsatfda.fda.gov/adafda/views/#/search
Verified source: https://api.fda.gov/animalandveterinary/event.json
Verified source: https://www.roxee.ai/conditions/
Verified source: /static/meds/images/gabapentin.jpg
Last refreshed: Aug 6, 2026, 7:47 p.m.
Last verified: Apr 15, 2026, 10:04 a.m.
Validation status: Incomplete

Add to My Pet's Medications

Choose a pet, confirm current or past, and optionally add reminder notes.

Pet Owner Quick Guide

Start here first for the safest next-step summary before the deeper medication detail.

Used for:

Used for neuropathic pain and as an adjunct for seizure control; also used for situational anxiety/sedation in some cases.

Dosing note:

Exact dosing depends on your pet's species, weight, and health status. Use your veterinarian's instructions for the exact dose and schedule.

What to watch for:

Use caution with kidney disease
dose adjustments may be needed
Thrombocytopenia (4 reports)
Elevated symmetrical dimethylarginine (4 reports)
Conjunctivitis (3 reports)

When to call the vet:

Repeated vomiting or diarrhea.
Severe lethargy (hard to wake, very low energy).
Collapse or fainting.
Trouble breathing.
Facial swelling or hives.
Blood in vomit or stool.

What to tell or ask your vet today:

Is this medicine the right fit for my pet’s current symptoms?
Which warning signs mean I should call back right away?
How should I handle missed doses or refusal to take the medicine?

Next actions

Talk to a Vet / Find a Vet Near You Save to pet meds Share page Review report evidence

Research brief

Medication Research Insights

A source-aware map of what to know, what is uncertain, and what to verify with your veterinarian.

Source Backed Signals

What to know

Evidence-backed context Limited

Roxee has limited cited overview evidence for Gabapentin; use the official documents and your veterinarian's instructions for product-specific decisions.

Source: openFDA reaction aggregate term

Safety signal coverage Reported signals

32 tracked reaction signals; 60 reported cases; 7 serious reports; 2 species groups. These are reporting and label-derived signals for interpretation with a veterinarian.

Source: openFDA reaction aggregate term

Interpretation guardrail Not causation

Adverse-event reports help form a watch list, but they do not prove the medication caused the reaction and they are not a risk ranking between medications.

Evidence tension

Stronger signal Label / review

Official labels, package inserts, and reviewed summaries carry more weight than isolated reports.

Source: openFDA reaction aggregate term

Weaker signal Reported data

Case reports and openFDA terms are useful for pattern awareness, but they are incomplete, can include multiple exposures, and do not estimate an individual pet's probability of harm.

Reaction signal map

Most reported reactions Top terms

Thrombocytopenia (4 reports), Elevated symmetrical dimethylarginine (4 reports), Conjunctivitis (3 reports), Urolithiasis (2 reports), Unclassifiable adverse event (2 reports)

Body systems represented Signal grouping

Effectiveness (1), Other (31)

Explore supporting adverse reports

Species and breed lens

Species represented in reports Species lens

Dog (48 reports), Cat (12 reports)

Breed metadata in reports Metadata only

Domestic Shorthair (2), Retriever - Labrador (2), Schnauzer - Miniature (1), Crossbred Canine/dog (1). These are report metadata, not proof that a breed is at higher risk.

What your vet may verify

Fit for this patient Vet check

Verify whether Gabapentin fits the pet's species, current diagnosis, age, weight, organ status, pregnancy/lactation status, and concurrent medications.

Evidence limitations Evidence review

Separate label-backed warnings from adverse-event reports and owner observations before changing the plan.

What to watch next

Watch list Owner-safe

Use caution with kidney disease, dose adjustments may be needed, Thrombocytopenia, Elevated symmetrical dimethylarginine, Conjunctivitis

Call sooner if Escalation

Repeated vomiting or diarrhea. Severe lethargy (hard to wake, very low energy). Collapse or fainting.

Bottom line: Use this Gabapentin brief as a structured watch list and source map, not as a reason to start, stop, or change treatment without your veterinarian.

Vet source depth

openFDA reaction aggregate term · adverse_reaction · adverse reactions
Medication contraindications · safety_warning · warnings contraindications
Structured Product Label · document · documents
Structured Product Label · document · documents
Structured Product Label · document · documents
Structured Product Label · document · documents

Evidence

Review status / Updated / Sources

Review status: Clinical reviewer not listed

Updated: April 15, 2026, 10:04 AM UTC

Sources:

Medication contraindications · safety_warning
openFDA reaction aggregate term · adverse_reaction
Structured Product Label · document
Structured Product Label · document
Structured Product Label · document

Safety & side effects

Side effects to monitor:

Use caution with kidney disease
dose adjustments may be needed
Thrombocytopenia
Elevated symmetrical dimethylarginine
Conjunctivitis

Most reported reactions:

Thrombocytopenia (4 reports)
Elevated symmetrical dimethylarginine (4 reports)
Conjunctivitis (3 reports)

Explore reported case details

Emergency warning signs:

Repeated vomiting or diarrhea.
Severe lethargy (hard to wake, very low energy).
Collapse or fainting.
Trouble breathing.

Talk to a Vet / Find a Vet Near You Start Symptom Intake

Vet Fast Scan

Source-backed clinical checkpoints for quick review.

FDA-labeled species

Not linked yet

Indication / use

Used for neuropathic pain and as an adjunct for seizure control; also used for situational anxiety/sedation in some cases.

Form / route / dose

Confirm product label and patient-specific plan.

Warnings

High: Use caution with kidney disease; dose adjustments may be needed.

Adverse-event caveat

openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.

Source docs

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both

Manufacturer: Multiple FDA labelers

Identifiers:

NDC Package: 46144-600-01 NDC Package: 62157-711-01 NDC Package: 73377-176-01 NDC Package: 86032-041-01 NDC Product: 46144 NDC Product: 62157 NDC Product: 73377 NDC Product: 86032

Warnings / Contraindications

Use caution with kidney disease; dose adjustments may be needed.

High: Use caution with kidney disease; dose adjustments may be needed.

Source metadata:

https://animaldrugsatfda.fda.gov · safety_warning · Medication contraindications

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Reported case explorer

Filter stored openFDA reports by pet and report attributes. Counts describe reports in this data set, not risk.

Clear filters

openFDA adverse-event cases are reported signals. They are not verified, do not prove causation, and do not estimate a pet's individual risk.

Stored reports

164

Matching reports

Active filters

Selected filters

Reaction: Lethargy (see also Central nervous system depression in Neurological) Clear Body system: Other Clear

Species

Breed

Size / weight

Age

Sex

Seriousness

Outcome

Reaction

Body system

Region

Received after

Received before

Reset

Drill into common report signals

Lethargy (see also Central nervous system depression in Neurological) (35) Abnormal radiograph finding (22) Death by euthanasia (18) Intentional misuse (18) Other (152) Neurologic (62) Digestive (50) Skin & allergy (27)

Showing up to 50 matching reports.

USA-USFDACVM-2026-US-014449

Received 2026-03-25 · MSK · MSK

Serious

Species: Dog
Breed: Schnauzer - Miniature
Size / weight: 10-24 lb (10.16 Kilogram)
Age: 4-7 years (5 Year)
Sex: Male Neutered
Region: USA
Reactions: LamenessWobblinessLethargy (see also Central nervous system depression in Neurological)Unable to walkWeaknessFeverImmune-mediated polyarthritisGastritisAbdominal cavity disorder NOSAbnormal ultrasound findingHyperproteinaemiaLymphopeniaEosinopeniaMedication error NOS
Body systems: OtherNeurologic
Outcomes: Ongoing

USA-USFDACVM-2026-US-014374

Received 2026-03-25 · MSK · MSK

Serious

Species: Dog
Breed: Crossbred Canine/dog
Size / weight: 50-99 lb (32.205 Kilogram)
Age: 8+ years (1 Year)
Sex: Male Neutered
Region: USA
Reactions: Musculoskeletal disorder NOSAggressionUnable to walkUrinary incontinenceMelaenaEmesis (multiple)Lethargy (see also Central nervous system depression in Neurological)Death by euthanasiaNeurological signs NOS
Body systems: OtherBehaviorDigestiveNeurologic
Outcomes: Euthanized

USA-USFDACVM-2026-US-013633

Received 2026-03-19 · MSK · MSK

Non-serious

Species: Cat
Breed: Domestic Shorthair
Size / weight: 10-24 lb (5.33 Kilogram)
Age: 8+ years (11 Year)
Sex: Female Neutered
Region: USA
Reactions: DysphoriaBehavioural disorder NOSDilated pupilsAnorexiaSkin and tissue infection NOSLethargy (see also Central nervous system depression in Neurological)
Body systems: OtherBehaviorDigestiveNeurologic
Outcomes: Recovered/Normal

USA-USFDACVM-2026-US-013169

Received 2026-03-19 · MSK · MSK

Serious

Species: Dog
Breed: Rottweiler
Size / weight: 50-99 lb (43.001 Kilogram)
Age: 8+ years (1 Year)
Sex: Male Neutered
Region: USA
Reactions: Musculoskeletal disorder NOSCollapse NOS (see also Cardio-vascular and Neurological disorders)Lethargy (see also Central nervous system depression in Neurological)Unable to walkNot eatingWeaknessDeath
Body systems: OtherNeurologic
Outcomes: Died

USA-USFDACVM-2026-US-012782

Received 2026-03-17 · MSK · MSK

Serious

Species: Dog
Breed: Setter - English
Size / weight: 25-49 lb (21.772 Kilogram)
Age: 8+ years (9 Year)
Sex: Male Neutered
Region: USA
Reactions: Dilated renal pelvisIntestinal thickeningAbnormal ultrasound findingBradycardiaPale mucous membraneDiarrhoeaWeight lossLethargy (see also Central nervous system depression in Neurological)LymphomaMedication error NOS
Body systems: OtherDigestiveNeurologic
Outcomes: Ongoing

USA-USFDACVM-2026-US-013278

Received 2026-03-16 · MSK · MSK

Serious

Species: Cat
Breed: Domestic Mediumhair
Size / weight: 10-24 lb (6.8 Kilogram)
Age: 8+ years (9 Year)
Sex: Male Neutered
Region: USA
Reactions: Injection site cystInjection site sarcomaInjection site lumpInjection site discharge NOSInjection site irritationLethargy (see also Central nervous system depression in Neurological)Elevated symmetrical dimethylarginine (SDMA)HypoalbuminaemiaThrombocytosisHyperkalaemiaAbnormal radiograph findingConstipationPain NOSAbnormal cytologyDecreased appetiteLicking at injection site
Body systems: OtherNeurologicDigestive
Outcomes: Ongoing

USA-USFDACVM-2026-US-013265

Received 2026-03-16 · MSK · MSK

Non-serious

Species: Dog
Breed: Corso Dog
Size / weight: 50-99 lb (42.184 Kilogram)
Age: 1-3 years (1 Year)
Sex: Female Neutered
Region: USA
Reactions: Lethargy (see also Central nervous system depression in Neurological)Not eatingFeverInjection site lumpApplication site serous discharge
Body systems: NeurologicOther
Outcomes: Ongoing

USA-USFDACVM-2026-US-013066

Received 2026-03-16 · MSK · MSK

Serious

Species: Dog
Breed: Samoyed
Size / weight: 50-99 lb (24.948 Kilogram)
Age: 8+ years (9 Year)
Sex: Male Neutered
Region: USA
Reactions: Lethargy (see also Central nervous system depression in Neurological)ShakingPale mucous membraneCold feeling of extremityVomitingTachycardiaLaboured breathingTachypnoeaDehydrationWeak pulseTense abdomenHypochloraemiaHyponatremiaAzotaemiaHypocalcaemiaHypoglycaemiaHyperphosphataemiaHypoproteinaemiaHypoalbuminaemiaLow alanine aminotransferase (ALT)Elevated lactateIncreased percentage reticulocytesLymphocytosisMonocytosisAbnormal red blood cellHypotensionAbdominal effusionAspiration pneumoniaHeart murmurGastric perforationLateral recumbencySepticaemiaCoagulopathyHypernatraemiaHypercalcaemiaElevated serum alkaline phosphatase (ALP)NeutrophiliaStridor (Upper respiratory; for lower respiratory see also Bronchial rale)Unresponsive to stimuliCyanotic mucous membranesThrombosisOedema of the extremities (see also other SOCs for most applicable oedema)Pitting oedemaLamenessElevated aspartate aminotransferase (AST)Stertor
Body systems: NeurologicOtherDigestive
Outcomes: Ongoing

USA-USFDACVM-2026-US-012478

Received 2026-03-16 · MSK · MSK

Serious

Species: Dog
Breed: ['Retriever - Labrador', 'Terrier - Bull - American Pit']
Size / weight: 50-99 lb (31.298 Kilogram)
Age: 8+ years (14 Year)
Sex: Female Neutered
Region: USA
Reactions: Limb weaknessDecreased appetiteDeath by euthanasiaLethargy (see also Central nervous system depression in Neurological)Panting
Body systems: OtherDigestiveNeurologic
Outcomes: Euthanized

USA-USFDACVM-2026-US-011996

Received 2026-03-13 · MSK · MSK

Serious

Species: Dog
Breed: Terrier - Bull - American Pit
Size / weight: 50-99 lb (29.937 Kilogram)
Age: 4-7 years (5 Year)
Sex: Male Neutered
Region: USA
Reactions: Injection site painAnorexiaFeverInjection site swellingInjection site abscessLethargy (see also Central nervous system depression in Neurological)
Body systems: OtherDigestiveSkin & allergyNeurologic
Outcomes: Ongoing

USA-USFDACVM-2026-US-011895

Received 2026-03-11 · MSK · MSK

Serious

Species: Cat
Breed: Domestic Shorthair
Size / weight: Under 10 lb (4.377 Kilogram)
Age: 1-3 years (1.5 Year)
Sex: Female Unknown
Region: USA
Reactions: VomitingLocalised pain NOS (see other SOCs for specific pain)Limb non-weight bearingLethargy (see also Central nervous system depression in Neurological)Not eatingHead tremorIncreased respiratory ratePlantigrade postureLimb weaknessProprioception deficitCutaneous emphysemaAbnormal radiograph findingKnuckling
Body systems: DigestiveOtherNeurologic
Outcomes: Ongoing

USA-USFDACVM-2026-US-011648

Received 2026-03-10 · MSK · MSK

Serious

Species: Cat
Breed: Domestic Shorthair
Size / weight: 10-24 lb (5.126 Kilogram)
Age: 4-7 years (5 Year)
Sex: Female Neutered
Region: USA
Reactions: Emesis (multiple)Weight lossLethargy (see also Central nervous system depression in Neurological)Blood in vomitAbnormal ultrasound findingWeaknessDecreased appetiteINEFFECTIVE, ANTIEMETICDigestive tract disorder NOS
Body systems: DigestiveOtherNeurologic
Outcomes: Ongoing

USA-USFDACVM-2026-US-010089

Received 2026-03-07 · MSK · MSK

Serious

Species: Cat
Breed: Domestic Shorthair
Size / weight: 10-24 lb (5.4 Kilogram)
Age: 8+ years (14 Year)
Sex: Male Neutered
Region: USA
Reactions: HypotensionBradycardiaHypernatraemiaLying downLethargy (see also Central nervous system depression in Neurological)Reduced responses
Body systems: OtherNeurologic
Outcomes: Recovered/Normal

USA-USFDACVM-2026-US-008769

Received 2026-02-28 · MSK · MSK

Serious

Species: Cat
Breed: Russian
Size / weight: Under 10 lb (4.3 Kilogram)
Age: 8+ years (19 Year)
Sex: Male Neutered
Region: USA
Reactions: Not drinkingNot eatingDullnessAnaemia NOSCardiac disorder NOSHeart murmurPale mucous membraneAtaxiaOliguriaRenal failureDeath by euthanasiaInappetenceLethargy (see also Central nervous system depression in Neurological)AscitesThird eyelid protrusionLateral recumbencyAcute renal failureDehydrationProlonged capillary refill timeHyperglycaemiaSplenic neoplasm NOSHead bobbingElevated blood urea nitrogen (BUN)Elevated creatinineAbnormal radiograph findingAzotaemiaDecreased packed cell volume (PCV)DullHypernatraemia
Body systems: OtherNeurologic
Outcomes: Euthanized

USA-USFDACVM-2026-US-009056

Received 2026-02-26 · MSK · MSK

Serious

Species: Dog
Breed: Terrier - Bull - American Pit
Size / weight: 50-99 lb (28.49 Kilogram)
Age: 8+ years (8.42 Year)
Sex: Female Unknown
Region: USA
Reactions: Weight lossLethargy (see also Central nervous system depression in Neurological)Limb weakness
Body systems: OtherNeurologic
Outcomes: Ongoing

USA-USFDACVM-2026-US-008246

Received 2026-02-24 · MSK · MSK

Serious

Species: Dog
Breed: Retriever - Labrador
Size / weight: 100+ lb (48.08 Kilogram)
Age: 4-7 years (7.5 Year)
Sex: Male Neutered
Region: USA
Reactions: Death by euthanasiaNot himself/herselfLethargy (see also Central nervous system depression in Neurological)VomitingHaemorrhage NOSWeight lossSternoabdominal recumbencyDehydrationDiabetic ketoacidosisAcute pancreatitisAzotaemia
Body systems: OtherNeurologicDigestive
Outcomes: Euthanized

USA-USFDACVM-2026-US-006203

Received 2026-02-10 · MSK · MSK

Serious

Species: Dog
Breed: Mountain Dog - Bernese
Size / weight: 50-99 lb (35.698 Kilogram)
Age: 4-7 years (7 Year)
Sex: Female Unknown
Region: USA
Reactions: Lethargy (see also Central nervous system depression in Neurological)InappetenceSwollen lip (see also Skin)Localised pain NOS (see other SOCs for specific pain)Ocular dischargeNot drinkingSmelly breathLip smackingWalking difficultyAbdominal painDrooping eyelidReluctant to moveOral ulcerationTongue ulcerationIntentional misuse
Body systems: NeurologicOther
Outcomes: Ongoing

USA-USFDACVM-2026-US-007418

Received 2026-02-09 · MSK · MSK

Serious

Species: Cat
Breed: Domestic Shorthair
Size / weight: 10-24 lb (8.7 Kilogram)
Age: 1-3 years (2.8 Year)
Sex: Male Neutered
Region: USA
Reactions: Lack of efficacy - NOSNot eatingLethargy (see also Central nervous system depression in Neurological)General pain (see other SOCs for specific pain)Facial oedemaTrigeminus paralysisOral ulcerationIntentional misuse
Body systems: EffectivenessOtherNeurologic
Outcomes: Ongoing

USA-USFDACVM-2026-US-004494

Received 2026-02-03 · MSK · MSK

Serious

Species: Cat
Breed: Domestic Mediumhair
Size / weight: 10-24 lb (6.804 Kilogram)
Age: 8+ years (9 Year)
Sex: Male Neutered
Region: USA
Reactions: Injection site cystInjection site sarcomaInjection site lumpInjection site discharge NOSInjection site irritationLethargy (see also Central nervous system depression in Neurological)Elevated symmetrical dimethylarginine (SDMA)HypoalbuminaemiaThrombocytosisHyperkalaemiaAbnormal radiograph findingConstipationPain NOSAbnormal cytologyDecreased appetiteLicking at injection site
Body systems: OtherNeurologicDigestive
Outcomes: Ongoing

USA-USFDACVM-2026-US-003352

Received 2026-01-27 · MSK · MSK

Serious

Species: Cat
Breed: Domestic Shorthair
Size / weight: Under 10 lb (3.992 Kilogram)
Age: 8+ years (13 Year)
Sex: Female Neutered
Region: USA
Reactions: DiarrhoeaDecreased appetiteLethargy (see also Central nervous system depression in Neurological)Bloody diarrhoeaDry mucous membraneOpen mouth breathingUnresponsive to stimuliDecreased haematocritIncreased percentage reticulocytesRegenerative anaemiaIntentional misuseThrombocytopeniaHypersalivationHeart murmur
Body systems: DigestiveNeurologicOther
Outcomes: Ongoing

USA-USFDACVM-2026-US-003528

Received 2026-01-19 · MSK · MSK

Serious

Species: Cat
Breed: Domestic Shorthair
Size / weight: Under 10 lb (4 Kilogram)
Age: 8+ years (13 Year)
Sex: Female Neutered
Region: USA
Reactions: Unresponsive to stimuliOpen mouth breathingAnorexiaLethargy (see also Central nervous system depression in Neurological)DiarrhoeaDry mucous membraneBloody diarrhoeaIncreased percentage reticulocytesDecreased haematocritRegenerative anaemiaThrombocytopeniaHypersalivationMurmur
Body systems: OtherDigestiveNeurologic
Outcomes: Ongoing

USA-USFDACVM-2026-US-003268

Received 2026-01-14 · MSK · MSK

Serious

Species: Dog
Breed: Dachshund (unspecified)
Size / weight: 10-24 lb (5.8 Kilogram)
Age: 8+ years (15 Year)
Sex: Male Neutered
Region: USA
Reactions: VomitingLethargy (see also Central nervous system depression in Neurological)RetchingDental diseaseDry mucous membraneDehydrationAnorexiaBloody diarrhoeaIncreased heart rateIncreased respiratory ratePale mucous membraneJaundiceHeart murmurTense abdomenLeukocytosis NOSNeutrophiliaLymphocytosisMonocytosisLow platelet countAzotaemiaElevated blood urea nitrogen (BUN)HyperphosphataemiaElevated alanine aminotransferase (ALT)Elevated serum alkaline phosphatase (ALP)Elevated total bilirubinElevated cholesterol (total)Blood in urineProteinuriaLiver disorder NOSPancreas disorderIntestinal thickeningUrinary tract disorder NOSNon-regenerative anaemiaHypokalaemiaNot eatingDecreased red blood cell countDecreased haematocritPolyuriaPolydipsiaAbdominal discomfortIncreased percentage reticulocytesPlatelet disorder NOSLack of efficacy - NOSGut sounds decreasedOther blood disorder NOSBilirubinuriaAbnormal ultrasound findingElevated gamma-glutamyl transferase (GGT)ThrombocytosisIleus
Body systems: DigestiveNeurologicOtherEffectiveness
Outcomes: Ongoing

USA-USFDACVM-2025-US-075421

Received 2025-12-29 · MSK · MSK

Serious

Species: Dog
Breed: Shepherd Dog - German
Size / weight: 25-49 lb (20.865 Kilogram)
Age: 8+ years (11 Year)
Sex: Female Unknown
Region: USA
Reactions: Emesis (multiple)Not eatingLethargy (see also Central nervous system depression in Neurological)Reluctant to moveSeizure NOS
Body systems: DigestiveOtherNeurologic
Outcomes: Ongoing

USA-USFDACVM-2025-US-075044

Received 2025-12-23 · MSK · MSK

Serious

Species: Dog
Breed: Siberian Husky
Size / weight: 50-99 lb (26.58 Kilogram)
Age: 8+ years (11 Year)
Sex: Female Neutered
Region: USA
Reactions: Clonic seizureBiting -aggression (see also Skin and appendages disorders)Partial blindnessSeizure NOSFoaming at the mouthOral bleedingLethargy (see also Central nervous system depression in Neurological)WobblinessUnable to focusUrinationLateral recumbencyVocalisationBalance problemStaringElevated alanine aminotransferase (ALT)Elevated serum alkaline phosphatase (ALP)
Body systems: NeurologicBehaviorOther
Outcomes: Ongoing

USA-USFDACVM-2025-US-074895

Received 2025-12-19 · MSK · MSK

Serious

Species: Dog
Breed: Bloodhound
Size / weight: 50-99 lb (41.28 Kilogram)
Age: 4-7 years (5 Year)
Sex: Female Neutered
Region: USA
Reactions: Lethargy (see also Central nervous system depression in Neurological)Stiffness NOSWalking difficultyGeneralised weaknessNeutropeniaLow platelet countPain NOSDecreased appetiteVomitingElevated liver enzymes NOSFluid in abdomen NOSLiver disorder NOSOther immune system disorder NOSFeverLeucopenia NOSDistension of abdomenHypoglycaemiaAnaemia NOSIndigestion
Body systems: NeurologicOtherDigestive
Outcomes: Ongoing

USA-USFDACVM-2025-US-074457

Received 2025-12-19 · MSK · MSK

Serious

Species: Dog
Breed: ['Beagle', 'Dog (unknown)']
Size / weight: 25-49 lb (14.061 Kilogram)
Age: 1-3 years (3.5 Year)
Sex: Male Neutered
Region: USA
Reactions: Lethargy (see also Central nervous system depression in Neurological)AgitationSeizure NOSElevated symmetrical dimethylarginine (SDMA)FallingStiffness NOSConfusionShivering
Body systems: NeurologicOther
Outcomes: Outcome Unknown

USA-USFDACVM-2025-US-072814

Received 2025-12-10 · MSK · MSK

Serious

Species: Dog
Breed: Pinscher - Miniature
Size / weight: Under 10 lb (4.037 Kilogram)
Age: 8+ years (1 Year)
Sex: Female Unknown
Region: USA
Reactions: Lethargy (see also Central nervous system depression in Neurological)TremblingLimpingHead downWalking difficultyFeverLack of efficacy - NOSElevated globulinsBlood in urineImmune-mediated polyarthropathyElevated protein:creatinine ratioProteinuriaIntentional misuse
Body systems: NeurologicOtherEffectiveness
Outcomes: Ongoing

USA-USFDACVM-2025-US-072729

Received 2025-12-05 · MSK · MSK

Non-serious

Species: Dog
Breed: Terrier - Bull
Size / weight: 25-49 lb (17.6 Kilogram)
Age: 4-7 years (7 Year)
Sex: Female Neutered
Region: USA
Reactions: Leucopenia NOSAnaemia NOSHypoalbuminaemiaNeutropeniaPyodermaReduced globulinsHypophosphataemiaNon-regenerative anaemiaLow serum alkaline phosphatase (ALP)Pale mucous membraneElevated alanine aminotransferase (ALT)Decreased packed cell volume (PCV)Lethargy (see also Central nervous system depression in Neurological)HypocalcaemiaElevated aspartate aminotransferase (AST)HypoproteinaemiaProteinuriaElectrolyte disorderDisorder of red blood cell NOSElevated creatine-kinase (CK)Other coagulation investigation abnormalityIncreased band neutrophiliaElevated mean corpuscular volume (MCV)LymphopeniaOther abnormal test result NOSDiarrhoeaPanleucopeniaEosinopeniaDecreased haematocritIncreased percentage reticulocytes
Body systems: OtherNeurologicDigestive
Outcomes: Ongoing

USA-USFDACVM-2025-US-072504

Received 2025-12-04 · MSK · MSK

Serious

Species: Dog
Breed: Terrier - Bull - American Pit
Size / weight: 50-99 lb (29.03 Kilogram)
Age: 1-3 years (2 Year)
Sex: Male Neutered
Region: USA
Reactions: Otitis externaTrigeminus paralysisVomitingCoughMuscle atrophy (see also Muscle wasting)Elevated serum alkaline phosphatase (ALP)Elevated alanine aminotransferase (ALT)HypersalivationUnusual stool colourErythema (for urticaria see Immune SOC)Elevated gamma-glutamyl transferase (GGT)Elevated total bilirubinAbnormal ultrasound findingHepatic fibrosisHepatitisLethargy (see also Central nervous system depression in Neurological)AngioedemaGeneralised rashDyspnoeaIncreased lung soundsLeucocytosis NOSIcterusAbnormal radiograph findingJaw disorder
Body systems: OtherDigestiveSkin & allergyNeurologic
Outcomes: Ongoing

USA-USFDACVM-2025-US-072463

Received 2025-12-01 · MSK · MSK

Non-serious

Species: Dog
Breed: ['Rottweiler', 'Retriever - Labrador']
Size / weight: 50-99 lb (27.76 Kilogram)
Age: 8+ years (14 Year)
Sex: Male Neutered
Region: USA
Reactions: Proprioception deficitMusculoskeletal disorder NOSLethargy (see also Central nervous system depression in Neurological)AnorexiaReluctant to moveBradycardiaArrhythmiaPyrexiaLymphocytosisLeucocytosis NOSLow thyroxine (T4)Elevated symmetrical dimethylarginine (SDMA)Urinary tract infection
Body systems: OtherNeurologicDigestive
Outcomes: Ongoing

USA-USFDACVM-2025-US-072107

Received 2025-12-01 · MSK · MSK

Serious

Species: Dog
Breed: Shepherd Dog - German
Size / weight: 50-99 lb (40.1 Kilogram)
Age: 8+ years (10.5 Year)
Sex: Male Neutered
Region: USA
Reactions: VocalisationAbnormal tail posturePain NOSWeight lossDecreased appetiteVomitingChewing disorderPantingTremblingLying downAnxietyExcessive chewing, licking and/or groomingMuscle atrophy (see also Muscle wasting)Musculoskeletal disorder NOSAbnormal radiograph findingSpondylosisJoint effusionElevated gamma-glutamyl transferase (GGT)LymphopeniaLethargy (see also Central nervous system depression in Neurological)Thoracic painDeath by euthanasiaMedication error NOS
Body systems: OtherDigestiveBehaviorNeurologic
Outcomes: Euthanized

USA-USFDACVM-2025-US-075182

Received 2025-11-24 · MSK · MSK

Serious

Species: Cat
Breed: Domestic Shorthair
Size / weight: 10-24 lb (4.76 Kilogram)
Age: 8+ years (11 Year)
Sex: Male Neutered
Region: USA
Reactions: Cold feeling to the touchDecreased appetiteLack of efficacy - NOSBehavioural disorder NOSVomitingRenal disorder NOSLethargy (see also Central nervous system depression in Neurological)Elevated renal parametersArthritisReluctant to moveWeight gainWobblinessDental diseaseRespiratory tract infection NOSAnaemia NOSElevated creatinineHypercalcaemiaFeverDehydrationDiarrhoeaDecreased haematocritDecreased red blood cell countDigestive tract disorder NOSSicknessDistressDiabetesDecreased body temperatureDeath by euthanasia
Body systems: OtherDigestiveEffectivenessBehaviorNeurologic
Outcomes: Euthanized

USA-USFDACVM-2025-US-070121

Received 2025-11-21 · MSK · MSK

Non-serious

Species: Dog
Breed: ['Shepherd Dog - German', 'Dog (unknown)']
Size / weight: 50-99 lb (36.015 Kilogram)
Age: 8+ years (12 Year)
Sex: Male Neutered
Region: USA
Reactions: Lethargy (see also Central nervous system depression in Neurological)Decreased appetiteWobblinessNot himself/herself
Body systems: NeurologicDigestiveOther
Outcomes: Ongoing

USA-USFDACVM-2025-US-067000

Received 2025-11-14 · MSK · MSK

Serious

Species: Cat
Breed: Domestic Shorthair
Size / weight: Under 10 lb (3.992 Kilogram)
Age: 8+ years (13 Year)
Sex: Female Unknown
Region: USA
Reactions: DiarrhoeaDecreased appetiteLethargy (see also Central nervous system depression in Neurological)Bloody diarrhoeaDry mucous membraneOpen mouth breathingUnresponsive to stimuliDecreased haematocritIncreased percentage reticulocytesRegenerative anaemiaIntentional misuseUnderdoseThrombocytopeniaHeart murmurHypersalivation
Body systems: DigestiveNeurologicOther
Outcomes: Ongoing

USA-USFDACVM-2025-US-068234

Received 2025-11-12 · MSK · MSK

Serious

Species: Cat
Breed: Cat (unknown)
Sex: Mixed Unknown
Region: USA
Reactions: DeathHaematocheziaDecreased appetiteRegurgitationLethargy (see also Central nervous system depression in Neurological)DiarrhoeaDeath by euthanasia
Body systems: OtherDigestiveNeurologic
Outcomes: DiedEuthanizedOutcome Unknown

Tap or hover a reaction to see what it means in plain language.

Tracked signals

Reported cases

Serious reports

Species represented

Grouped by Body System

Effectiveness (1) · Lack of efficacy (endoparasite) - tapeworm Other (31) · Thrombocytopenia, Elevated symmetrical dimethylarginine, Conjunctivitis

Most Reported Reactions

Body system	Cases	Species
Other	4	Dog
Other	4	Dog
Other	3	Dog
Other	2	Dog
Other	2	Dog
Other	2	Dog
Other	2	Dog
Other	2	Dog

Species coverage: Dog (48) Cat (12)

View detailed reaction table

Body system	Species	Seriousness	Frequency	Reports
Other	Dog	Unknown	-	4
Other	Dog	Unknown	-	4
Other	Dog	Unknown	-	3
Other	Dog	Unknown	-	2
Other	Dog	Unknown	-	2
Other	Dog	Unknown	-	2
Other	Dog	Unknown	-	2
Other	Dog	Unknown	-	2
Other	Dog	Unknown	-	2
Other	Dog	Unknown	-	2
Other	Dog	Unknown	-	2
Other	Dog	Unknown	-	2
Effectiveness	Dog	Unknown	-	2
Other	Dog	Unknown	-	2
Other	Dog	Unknown	-	2
Other	Cat	Unknown	-	2
Other	Cat	Unknown	-	2
Other	Dog	Unknown	-	2
Other	Dog	Unknown	-	2
Other	Cat	Unknown	-	2
Other	Cat	Unknown	-	2
Other	Cat	Unknown	-	2
Other	Dog	Unknown	-	2
Other	Cat	Serious	-	1
Other	Dog	Non-serious	-	1
Other	Cat	Serious	-	1
Other	Dog	Unknown	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1
Other	Dog	Serious	-	1

Source metadata:

https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA reaction aggregate term

Storage & Handling

Store at room temperature.

Source Documents

The most useful source links appear first; full previews and metadata stay in the veterinary/professional layer.

Use original documents to confirm product-specific warnings, ingredients, and handling details with your veterinarian.

Gabapentin SPL SPL · Structured Product Label Gabapentin SPL SPL · Structured Product Label SolutitionKits SPL SPL · Structured Product Label

Full source previews and metadata remain in the veterinary/professional layer.

Owner handouts

No owner handouts linked yet.

Official label / PI

No official label or package insert links yet.

SPL

FOI

No FOI links yet.

Gabapentin SPL

SPL · Structured Product Label

Open original

FDA Structured Product Label XML for Gabapentin. Use the source link for the full official labeling record.

Gabapentin SPL

SPL · Structured Product Label

Open original

FDA Structured Product Label XML for Gabapentin. Use the source link for the full official labeling record.

SolutitionKits SPL

SPL · Structured Product Label

Open original

FDA Structured Product Label XML for SolutitionKits. Use the source link for the full official labeling record.

GABAPENTIN SPL

SPL · Structured Product Label

Open original

FDA Structured Product Label XML for GABAPENTIN. Use the source link for the full official labeling record.

Source metadata:

https://www.accessdata.fda.gov/spl/data/54945492-2e86-4f6d-99e0-d4f492ab0dc0/54945492-2e86-4f6d-99e0-d4f492ab0dc0.xml · document · Structured Product Label
https://www.accessdata.fda.gov/spl/data/de14dc38-395f-420b-89b9-f3c57e195149/de14dc38-395f-420b-89b9-f3c57e195149.xml · document · Structured Product Label
https://www.accessdata.fda.gov/spl/data/fc8d67a9-6118-481c-a1e4-53269e18b31d/fc8d67a9-6118-481c-a1e4-53269e18b31d.xml · document · Structured Product Label
https://www.accessdata.fda.gov/spl/data/346c35fb-8599-4556-9804-a4452af8bb91/346c35fb-8599-4556-9804-a4452af8bb91.xml · document · Structured Product Label

Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness

Reference facts: Source Roxee | Refreshed Aug 6, 2026, 7:47 PM UTC
The reference fact projection used for browse cards and quick facts.
Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Aug 6, 2026, 7:47 PM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
openFDA reaction terms: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC
openFDA case summaries: Source FDA openFDA | Refreshed Aug 6, 2026, 7:52 PM UTC

Official (FDA)

Identity: Generic ingredient • FDA branded products available

Official FDA brands: GABAPENTIN Gabapentin SolutitionKits

Manufacturer mapping: Multiple FDA labelers

Case-reported brands (openFDA): MSK

Catalog species: Both

NDC: Packages 46144-600-01 62157-711-01 73377-176-01 86032-041-01 • Products 46144 62157 73377 86032

Safety (openFDA)

Top reactions: Dog 382 • Cat 273 • View

Case summaries: 164 (showing 8) • View

openFDA reports are unverified and do not prove causation.

Explore

Related conditions: Pain (acute, chronic)

Linked using: Usage_Inferred (0.78)

Diagnosis Codes

Diagnosis-code mappings are not available for this medication yet.

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Owner-facing counseling points

Use caution with kidney disease; dose adjustments may be needed. (Contraindication, High)

Top reaction signals

Thrombocytopenia (4) Elevated symmetrical dimethylarginine (4) Conjunctivitis (3) Urolithiasis (2) Unclassifiable adverse event (2) Trembling (2) Skin lesion NOS (2) Respiratory tract infection NOS (2)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers

NDC Package: 46144-600-01 NDC Package: 62157-711-01 NDC Package: 73377-176-01 NDC Package: 86032-041-01 NDC Product: 46144 NDC Product: 62157 NDC Product: 73377 NDC Product: 86032

Package NDC	Product NDC	Status
46144-600-01	46144	-
62157-711-01	62157	-
73377-176-01	73377	-
86032-041-01	86032	-

Enriched Documents

Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.

Gabapentin SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
Gabapentin SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
SolutitionKits SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.
GABAPENTIN SPL • Structured Product Label • Official
FDA Structured Product Label from the electronic animal drug product listing directory.

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 4 Clinical 120 Manufacturer 0 Marketing 0

Marketing/Manufacturer content exists: 1 linked manufacturer ad video are attached to this medication.

Current Field Facts

contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-22)
contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-22)
contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-22)
contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-20)
contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-19)
contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-16)
contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-16)
contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-13)
contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-12)
contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-11)
contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-11)
contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-11)
contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-10)
contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-07)
contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-06)
contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-06)
contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-03)
contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-03)
contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-02)
contraindications: Use caution with kidney disease; dose adjustments may be needed. (Clinical, 2026-07-01)

Recent Revisions

side_effects updated 2026-07-22 19:08 by etl_backfill • Backfilled from existing medication fields
contraindications updated 2026-07-22 19:08 by etl_backfill • Backfilled from existing medication fields
usage updated 2026-07-22 19:08 by etl_backfill • Backfilled from existing medication fields
side_effects updated 2026-07-22 18:40 by etl_backfill • Backfilled from existing medication fields
contraindications updated 2026-07-22 18:40 by etl_backfill • Backfilled from existing medication fields
usage updated 2026-07-22 18:40 by etl_backfill • Backfilled from existing medication fields
side_effects updated 2026-07-22 08:29 by etl_backfill • Backfilled from existing medication fields
contraindications updated 2026-07-22 08:29 by etl_backfill • Backfilled from existing medication fields
usage updated 2026-07-22 08:29 by etl_backfill • Backfilled from existing medication fields
side_effects updated 2026-07-20 10:05 by etl_backfill • Backfilled from existing medication fields
contraindications updated 2026-07-20 10:05 by etl_backfill • Backfilled from existing medication fields
usage updated 2026-07-20 10:05 by etl_backfill • Backfilled from existing medication fields
side_effects updated 2026-07-19 13:48 by etl_backfill • Backfilled from existing medication fields
contraindications updated 2026-07-19 13:48 by etl_backfill • Backfilled from existing medication fields
usage updated 2026-07-19 13:48 by etl_backfill • Backfilled from existing medication fields
side_effects updated 2026-07-16 16:34 by etl_backfill • Backfilled from existing medication fields
contraindications updated 2026-07-16 16:34 by etl_backfill • Backfilled from existing medication fields
usage updated 2026-07-16 16:34 by etl_backfill • Backfilled from existing medication fields
side_effects updated 2026-07-16 15:43 by etl_backfill • Backfilled from existing medication fields
contraindications updated 2026-07-16 15:43 by etl_backfill • Backfilled from existing medication fields

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product	Sponsor	Application	Status	Published

Data source: FDA Animal Drugs @ FDA (public search export).

Usage

Used for neuropathic pain and as an adjunct for seizure control; also used for situational anxiety/sedation in some cases.

Contraindications

Use caution with kidney disease; dose adjustments may be needed.

Side Effects

Sedation, ataxia, mild GI upset.

Source: FDA openFDA • Reference

Top Reported Reactions (openFDA)

De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).

Effectiveness

Lack of efficacy (endoparasite) - tapeworm (2) • Dog

Showing top 5 for Effectiveness.

Other

Thrombocytopenia (4) • Dog Elevated symmetrical dimethylarginine (4) • Dog Conjunctivitis (3) • Dog Urolithiasis (2) • Dog Unclassifiable adverse event (2) • Dog

Show more (26)

Trembling (2) • Dog Skin lesion NOS (2) • Dog Respiratory tract infection NOS (2) • Dog Regurgitation (2) • Dog Reduced globulins (2) • Dog Pyoderma (2) • Dog Proprioception deficit (2) • Dog Knuckling (2) • Dog Hypophosphataemia (2) • Dog Hypokalaemia (2) • Cat Hepatomegaly (2) • Cat Fracture (2) • Dog Erythema (2) • Dog Elevated alanine aminotransferase (2) • Cat Decreased activity (2) • Cat Death (2) • Cat Confusion (2) • Dog Abnormal radiograph finding (1) • Cat Abnormal movement NOS (1) • Dog Abnormal menace reflex test (1) • Cat Abnormal histology NOS (1) • Dog Abnormal cytology (1) • Dog Abdominal pain (1) • Dog Abdominal effusion (1) • Dog Abdominal discomfort (1) • Dog Abdominal cavity disorder NOS (1) • Dog

Showing top 5 for Other.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Cat, Domestic Shorthair, Female, 11 year, 3.992 kilogram • Drug: MSK, Unassigned, Oral • Reactions: Facial pruritus, Medication error NOS • Outcome: Recovered/Normal

Report ID: USA-USFDACVM-2026-US-014454
Serious AE: No
Treated For AE: No
Sex: Female
Age: 11.00 Year
Weight: 3.992 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Oral
Form: Unassigned

Reactions Reported:

Facial pruritus Medication error NOS

Outcomes: Recovered/Normal

Dog, Retriever - Labrador, Male, 11 year, 47.174 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Partial lack of efficacy • Outcome: Ongoing

Report ID: USA-USFDACVM-2026-US-014361
Serious AE: Yes
Treated For AE: Yes
Sex: Male
Age: 11.00 Year
Weight: 47.174 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown
Form: Unassigned

Reactions Reported:

Partial lack of efficacy

Outcomes: Ongoing

Dog, Schnauzer - Miniature, Male, 5 year, 10.16 kilogram • Drug: MSK, Unassigned, Oral • Reactions: Lameness, Wobbliness, Tiredness (lethargy), Unable to walk, Weakness… • Outcome: Ongoing

Report ID: USA-USFDACVM-2026-US-014449
Serious AE: Yes
Treated For AE: Yes
Sex: Male
Age: 5.00 Year
Weight: 10.160 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Oral
Form: Unassigned

Reactions Reported:

Lameness Wobbliness Tiredness (lethargy) Unable to walk Weakness Fever Immune-mediated polyarthritis Gastritis Abdominal cavity disorder NOS Abnormal ultrasound finding Hyperproteinaemia Lymphopenia Eosinopenia Medication error NOS

Outcomes: Ongoing

Dog, Crossbred Canine/dog, Male, 10 year, 32.205 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Musculoskeletal disorder NOS, Aggression, Unable to walk, Urinary incontinence, Melaena… • Outcome: Euthanized

Report ID: USA-USFDACVM-2026-US-014374
Serious AE: Yes
Treated For AE: Yes
Sex: Male
Age: 10.00 Year
Weight: 32.205 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown
Form: Unassigned

Reactions Reported:

Musculoskeletal disorder NOS Aggression Unable to walk Urinary incontinence Melaena Vomiting Tiredness (lethargy) Death by euthanasia Neurological signs NOS

Outcomes: Euthanized

Dog, Retriever - Labrador, Unknown • Drug: MSK, Unknown • Reactions: Death • Outcome: Died

Report ID: USA-USFDACVM-2026-US-014204
Serious AE: Yes
Treated For AE: No
Sex: Unknown

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown

Reactions Reported:

Death

Outcomes: Died

Cat, Domestic Shorthair, Female, 20 year, 2.631 kilogram • Drug: MSK, Unassigned, Unknown • Reactions: Agitation, Vocalisation, Unsteady walking (ataxia), Weakness • Outcome: Recovered/Normal

Report ID: USA-USFDACVM-2026-US-014011
Serious AE: Yes
Treated For AE: Yes
Sex: Female
Age: 20.00 Year
Weight: 2.631 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown
Form: Unassigned

Reactions Reported:

Agitation Vocalisation Unsteady walking (ataxia) Weakness

Outcomes: Recovered/Normal

Dog, Retriever - Golden, Female, 4 year, 34.019 kilogram • Drug: MSK, Unassigned, Unknown, Dose: 300 Milligram per animal, Frequency: 12 per hour • Reactions: Lameness, Difficulty to rise, Joint swelling, Abnormal radiograph finding, Bone and joint disorder NOS… • Outcome: Ongoing

Report ID: USA-USFDACVM-2026-US-014065
Serious AE: Yes
Treated For AE: Yes
Sex: Female
Age: 4.00 Year
Weight: 34.019 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Unknown
Form: Unassigned
Dose: 300 Milligram per animal
Frequency: 12 per hour

Reactions Reported:

Lameness Difficulty to rise Joint swelling Abnormal radiograph finding Bone and joint disorder NOS Discomfort NOS

Outcomes: Ongoing

Dog, Shepherd Dog - German, Female, 9 year, 35.698 kilogram • Drug: MSK, Unassigned, Oral, Dose: 200 Milligram per animal, Frequency: 12 per hour • Reactions: Joint pain, Lameness, Depression, Difficulty standing, Decreased appetite… • Outcome: Outcome Unknown

Report ID: USA-USFDACVM-2026-US-014048
Serious AE: Yes
Treated For AE: Yes
Sex: Female
Age: 9.00 Year
Weight: 35.698 Kilogram

Case-reported brand: MSK
Case-reported manufacturer: MSK
Route: Oral
Form: Unassigned
Dose: 200 Milligram per animal
Frequency: 12 per hour

Reactions Reported:

Joint pain Lameness Depression Difficulty standing Decreased appetite Abnormal radiograph finding Bone and joint disorder NOS Joint effusion Spondylosis

Outcomes: Outcome Unknown

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

Overdose can cause severe sedation, loss of coordination, muscle tremors, and respiratory depression. Emergency care: IV fluids, monitoring.

Storage & Handling

Store at room temperature.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

No community reviews yet. Be the first to share your experience.

This medication has not been reviewed by a veterinarian yet.

Medical Disclaimer: The medication details provided on Roxee are for informational purposes only and are not a substitute for professional veterinary advice. Always consult your veterinarian about your pet's specific needs.

Gabapentin

Data freshness

Gabapentin

Medication Snapshot

Gabapentin

Indications / Uses

Administration / How To Give

Storage

Warnings / Contraindications

Side Effects

FAQ

What species is this commonly shown for?

How should this be stored?

Related Medications

Related Conditions

Source Transparency

Add to My Pet's Medications

Pet Owner Quick Guide

Next actions

Medication Research Insights

What to know

Evidence tension

Reaction signal map

Species and breed lens

What your vet may verify

What to watch next

Evidence

Vet Fast Scan

Quick Facts

Warnings / Contraindications

Adverse Reactions

Reported case explorer

USA-USFDACVM-2026-US-014449

USA-USFDACVM-2026-US-014374

USA-USFDACVM-2026-US-013633

USA-USFDACVM-2026-US-013169

USA-USFDACVM-2026-US-012782

USA-USFDACVM-2026-US-013278

USA-USFDACVM-2026-US-013265

USA-USFDACVM-2026-US-013066

USA-USFDACVM-2026-US-012478

USA-USFDACVM-2026-US-011996

USA-USFDACVM-2026-US-011895

USA-USFDACVM-2026-US-011648

USA-USFDACVM-2026-US-010089

USA-USFDACVM-2026-US-008769

USA-USFDACVM-2026-US-009056

USA-USFDACVM-2026-US-008246

USA-USFDACVM-2026-US-006203

USA-USFDACVM-2026-US-007418

USA-USFDACVM-2026-US-004494

USA-USFDACVM-2026-US-003352

USA-USFDACVM-2026-US-003528

USA-USFDACVM-2026-US-003268

USA-USFDACVM-2025-US-075421

USA-USFDACVM-2025-US-075044

USA-USFDACVM-2025-US-074895

USA-USFDACVM-2025-US-074457

USA-USFDACVM-2025-US-072814

USA-USFDACVM-2025-US-072729

USA-USFDACVM-2025-US-072504

USA-USFDACVM-2025-US-072463

USA-USFDACVM-2025-US-072107

USA-USFDACVM-2025-US-075182

USA-USFDACVM-2025-US-070121

USA-USFDACVM-2025-US-067000

USA-USFDACVM-2025-US-068234

Grouped by Body System

Most Reported Reactions

Storage & Handling

Source Documents

Owner handouts

Official label / PI

SPL

FOI

Gabapentin SPL

Gabapentin SPL

SolutitionKits SPL

GABAPENTIN SPL

At a Glance